News and Announcements
Amber is moving from Private Beta to Public Beta next week and have closed 90% of their $1m Seed round
- Published December 07, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
- The Amber team has officially closed 90% of their $1 million Seed round.
- The Amber App will be available to download from mobile stores.
- Amber is moving from Private beta to Public Beta next week.
Amber is moving from Private Beta to Public Beta next week.
This will allow people to download the app, link their account & slowly begin accumulating Bitcoin with their spare change.
The app will be available to download from all mobile stores.
If anyone interested in being a part of the Beta program, please email the team at: [email protected]
The Amber team has officially closed 90% of their $1 million Seed round, this is now the last chance to participate in a real equity round for one of the most innovative, real use-case products in the entire crypto market.
About Amber
Amber is a digital currency exchange, wallet and round up app – all in the palm of your hand.
Our mission is to make digital currencies easy, for everyday people. With Amber, you simply download the app, link your account and get on with your life. The spare change from each of your transactions is automatically converted into Bitcoin and Ethereum – like a digital piggy bank. It’s Australia’s first fully integrated digital currency exchange, wallet and micro-investment app, so not only can you buy with your spare change, but you can store, swap, send and sell.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
